nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylpropion—Methamphetamine—obesity	0.208	1	CrCtD
Diethylpropion—Increased Sympathetic Activity—Benzphetamine—obesity	0.0495	0.121	CiPCiCtD
Diethylpropion—Appetite Suppression—Phentermine—obesity	0.0495	0.121	CiPCiCtD
Diethylpropion—Increased Sympathetic Activity—Phentermine—obesity	0.0495	0.121	CiPCiCtD
Diethylpropion—Appetite Suppression—Benzphetamine—obesity	0.0495	0.121	CiPCiCtD
Diethylpropion—Appetite Suppression—Phendimetrazine—obesity	0.0495	0.121	CiPCiCtD
Diethylpropion—Increased Sympathetic Activity—Phendimetrazine—obesity	0.0495	0.121	CiPCiCtD
Diethylpropion—Appetite Suppression—Methamphetamine—obesity	0.0375	0.0916	CiPCiCtD
Diethylpropion—Increased Sympathetic Activity—Methamphetamine—obesity	0.0375	0.0916	CiPCiCtD
Diethylpropion—Appetite Suppression—Sibutramine—obesity	0.0375	0.0916	CiPCiCtD
Diethylpropion—SLC6A3—Phendimetrazine—obesity	0.019	0.105	CbGbCtD
Diethylpropion—SLC6A3—Sibutramine—obesity	0.019	0.105	CbGbCtD
Diethylpropion—SLC6A3—Benzphetamine—obesity	0.0144	0.0797	CbGbCtD
Diethylpropion—SLC6A3—Phentermine—obesity	0.0144	0.0797	CbGbCtD
Diethylpropion—SLC6A2—Phendimetrazine—obesity	0.0139	0.077	CbGbCtD
Diethylpropion—SLC6A2—Sibutramine—obesity	0.0139	0.077	CbGbCtD
Diethylpropion—SLC6A3—Phenylpropanolamine—obesity	0.0137	0.076	CbGbCtD
Diethylpropion—SLC6A3—Bupropion—obesity	0.0123	0.0678	CbGbCtD
Diethylpropion—Selegiline—Phentermine—obesity	0.0121	0.085	CrCrCtD
Diethylpropion—SLC6A3—Methamphetamine—obesity	0.0115	0.0637	CbGbCtD
Diethylpropion—Selegiline—Methamphetamine—obesity	0.0108	0.0758	CrCrCtD
Diethylpropion—SLC6A2—Benzphetamine—obesity	0.0105	0.0583	CbGbCtD
Diethylpropion—SLC6A2—Phentermine—obesity	0.0105	0.0583	CbGbCtD
Diethylpropion—SLC6A2—Phenylpropanolamine—obesity	0.0101	0.0557	CbGbCtD
Diethylpropion—Amphetamine—Phenylpropanolamine—obesity	0.00982	0.0691	CrCrCtD
Diethylpropion—Dextroamphetamine—Phenylpropanolamine—obesity	0.00982	0.0691	CrCrCtD
Diethylpropion—Methamphetamine—Phenylpropanolamine—obesity	0.00954	0.0671	CrCrCtD
Diethylpropion—SLC6A2—Bupropion—obesity	0.00897	0.0496	CbGbCtD
Diethylpropion—Selegiline—Benzphetamine—obesity	0.00854	0.0601	CrCrCtD
Diethylpropion—SLC6A2—Methamphetamine—obesity	0.00843	0.0466	CbGbCtD
Diethylpropion—Amphetamine—Phentermine—obesity	0.00835	0.0587	CrCrCtD
Diethylpropion—Dextroamphetamine—Phentermine—obesity	0.00835	0.0587	CrCrCtD
Diethylpropion—Methamphetamine—Phentermine—obesity	0.00811	0.057	CrCrCtD
Diethylpropion—L-Phenylalanine—Phenylpropanolamine—obesity	0.00747	0.0525	CrCrCtD
Diethylpropion—Amphetamine—Methamphetamine—obesity	0.00744	0.0523	CrCrCtD
Diethylpropion—Dextroamphetamine—Methamphetamine—obesity	0.00744	0.0523	CrCrCtD
Diethylpropion—L-Phenylalanine—Phentermine—obesity	0.00635	0.0447	CrCrCtD
Diethylpropion—Dextroamphetamine—Benzphetamine—obesity	0.0059	0.0415	CrCrCtD
Diethylpropion—Amphetamine—Benzphetamine—obesity	0.0059	0.0415	CrCrCtD
Diethylpropion—Methamphetamine—Benzphetamine—obesity	0.00573	0.0403	CrCrCtD
Diethylpropion—L-Phenylalanine—Methamphetamine—obesity	0.00566	0.0398	CrCrCtD
Diethylpropion—Ethopropazine—Benzphetamine—obesity	0.00491	0.0345	CrCrCtD
Diethylpropion—SLC6A2—sympathetic nervous system—obesity	0.00114	0.384	CbGeAlD
Diethylpropion—SLC6A2—autonomic nervous system—obesity	0.000767	0.258	CbGeAlD
Diethylpropion—SLC6A3—Clearance of dopamine—COMT—obesity	0.000435	0.0583	CbGpPWpGaD
Diethylpropion—SLC6A3—hindbrain—obesity	0.0004	0.135	CbGeAlD
Diethylpropion—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A14—obesity	0.000347	0.0465	CbGpPWpGaD
Diethylpropion—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—SLC22A1—obesity	0.000336	0.0451	CbGpPWpGaD
Diethylpropion—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A14—obesity	0.000307	0.0412	CbGpPWpGaD
Diethylpropion—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—obesity	0.000248	0.0333	CbGpPWpGaD
Diethylpropion—SLC6A3—respiratory system—obesity	0.000245	0.0823	CbGeAlD
Diethylpropion—SLC6A2—Amine compound SLC transporters—SLC6A14—obesity	0.000241	0.0323	CbGpPWpGaD
Diethylpropion—Amphetamine—CARTPT—obesity	0.000233	0.334	CrCbGaD
Diethylpropion—SLC6A3—Amine compound SLC transporters—SLC6A14—obesity	0.000213	0.0286	CbGpPWpGaD
Diethylpropion—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—obesity	0.000198	0.0266	CbGpPWpGaD
Diethylpropion—SLC6A2—respiratory system—obesity	0.000197	0.0664	CbGeAlD
Diethylpropion—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—obesity	0.00019	0.0255	CbGpPWpGaD
Diethylpropion—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—obesity	0.000168	0.0226	CbGpPWpGaD
Diethylpropion—SLC6A2—Amine compound SLC transporters—SLC22A1—obesity	0.000132	0.0177	CbGpPWpGaD
Diethylpropion—Milnacipran—SLC6A4—obesity	0.000128	0.183	CrCbGaD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A7—obesity	0.000124	0.0166	CbGpPWpGaD
Diethylpropion—SLC6A2—Monoamine Transport—TNFRSF11B—obesity	0.000122	0.0164	CbGpPWpGaD
Diethylpropion—SLC6A2—Monoamine Transport—HRH3—obesity	0.00012	0.0161	CbGpPWpGaD
Diethylpropion—SLC6A2—adrenal gland—obesity	0.00012	0.0402	CbGeAlD
Diethylpropion—SLC6A3—Amine compound SLC transporters—SLC22A1—obesity	0.000117	0.0157	CbGpPWpGaD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A7—obesity	0.00011	0.0147	CbGpPWpGaD
Diethylpropion—SLC6A3—Monoamine Transport—TNFRSF11B—obesity	0.000108	0.0145	CbGpPWpGaD
Diethylpropion—SLC6A3—Monoamine Transport—HRH3—obesity	0.000106	0.0143	CbGpPWpGaD
Diethylpropion—SLC6A2—endocrine gland—obesity	0.000104	0.0349	CbGeAlD
Diethylpropion—SLC6A2—Monoamine Transport—SLC6A4—obesity	9.75e-05	0.0131	CbGpPWpGaD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A14—obesity	9.41e-05	0.0126	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—CES1—obesity	8.95e-05	0.012	CbGpPWpGaD
Diethylpropion—SLC6A2—Monoamine Transport—NOS1—obesity	8.69e-05	0.0117	CbGpPWpGaD
Diethylpropion—SLC6A3—Monoamine Transport—SLC6A4—obesity	8.64e-05	0.0116	CbGpPWpGaD
Diethylpropion—Insomnia—Methamphetamine—obesity	8.56e-05	0.00176	CcSEcCtD
Diethylpropion—Tension—Phenylpropanolamine—obesity	8.55e-05	0.00175	CcSEcCtD
Diethylpropion—Nervousness—Phenylpropanolamine—obesity	8.46e-05	0.00174	CcSEcCtD
Diethylpropion—Blood pressure increased—Sibutramine—obesity	8.43e-05	0.00173	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A14—obesity	8.33e-05	0.0112	CbGpPWpGaD
Diethylpropion—Dyspepsia—Methamphetamine—obesity	8.33e-05	0.00171	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—ME1—obesity	8.32e-05	0.0112	CbGpPWpGaD
Diethylpropion—Insomnia—Benzphetamine—obesity	8.26e-05	0.0017	CcSEcCtD
Diethylpropion—Agranulocytosis—Cimetidine—obesity	8.24e-05	0.00169	CcSEcCtD
Diethylpropion—Vision blurred—Phenylpropanolamine—obesity	8.21e-05	0.00169	CcSEcCtD
Diethylpropion—Tension—Phentermine—obesity	8.18e-05	0.00168	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Methamphetamine—obesity	8.17e-05	0.00168	CcSEcCtD
Diethylpropion—Tremor—Phenylpropanolamine—obesity	8.16e-05	0.00168	CcSEcCtD
Diethylpropion—Tachycardia—Phendimetrazine—obesity	8.12e-05	0.00167	CcSEcCtD
Diethylpropion—Constipation—Methamphetamine—obesity	8.1e-05	0.00166	CcSEcCtD
Diethylpropion—Nervousness—Phentermine—obesity	8.09e-05	0.00166	CcSEcCtD
Diethylpropion—Dysmenorrhoea—Bupropion—obesity	8.08e-05	0.00166	CcSEcCtD
Diethylpropion—Hyperhidrosis—Phendimetrazine—obesity	8.04e-05	0.00165	CcSEcCtD
Diethylpropion—Dyspepsia—Benzphetamine—obesity	8.04e-05	0.00165	CcSEcCtD
Diethylpropion—Agitation—Phenylpropanolamine—obesity	8e-05	0.00164	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—CES1—obesity	7.93e-05	0.0106	CbGpPWpGaD
Diethylpropion—Gastrointestinal disorder—Benzphetamine—obesity	7.88e-05	0.00162	CcSEcCtD
Diethylpropion—Urine output increased—Orlistat—obesity	7.88e-05	0.00162	CcSEcCtD
Diethylpropion—Dyskinesia—Bupropion—obesity	7.82e-05	0.00161	CcSEcCtD
Diethylpropion—Tremor—Phentermine—obesity	7.81e-05	0.0016	CcSEcCtD
Diethylpropion—SLC6A3—Monoamine Transport—NOS1—obesity	7.7e-05	0.0103	CbGpPWpGaD
Diethylpropion—Agitation—Phentermine—obesity	7.66e-05	0.00157	CcSEcCtD
Diethylpropion—Ecchymosis—Sibutramine—obesity	7.62e-05	0.00157	CcSEcCtD
Diethylpropion—Insomnia—Phendimetrazine—obesity	7.53e-05	0.00155	CcSEcCtD
Diethylpropion—Urticaria—Methamphetamine—obesity	7.52e-05	0.00154	CcSEcCtD
Diethylpropion—Anxiety—Phenylpropanolamine—obesity	7.39e-05	0.00152	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—ME1—obesity	7.37e-05	0.00988	CbGpPWpGaD
Diethylpropion—Palpitations—Phentermine—obesity	7.36e-05	0.00151	CcSEcCtD
Diethylpropion—Blood pressure increased—Bupropion—obesity	7.35e-05	0.00151	CcSEcCtD
Diethylpropion—Levomilnacipran—SLC6A4—obesity	7.35e-05	0.105	CrCbGaD
Diethylpropion—Urticaria—Benzphetamine—obesity	7.25e-05	0.00149	CcSEcCtD
Diethylpropion—Euphoric mood—Sibutramine—obesity	7.24e-05	0.00149	CcSEcCtD
Diethylpropion—Polyuria—Orlistat—obesity	7.2e-05	0.00148	CcSEcCtD
Diethylpropion—Etomidate—CYP19A1—obesity	7.15e-05	0.102	CrCbGaD
Diethylpropion—Constipation—Phendimetrazine—obesity	7.12e-05	0.00146	CcSEcCtD
Diethylpropion—Chest pain—Phentermine—obesity	7.1e-05	0.00146	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—FTL—obesity	7.08e-05	0.00949	CbGpPWpGaD
Diethylpropion—Alopecia—Cimetidine—obesity	7e-05	0.00144	CcSEcCtD
Diethylpropion—Dry mouth—Phentermine—obesity	6.94e-05	0.00142	CcSEcCtD
Diethylpropion—Bone marrow depression—Topiramate—obesity	6.94e-05	0.00142	CcSEcCtD
Diethylpropion—Tachycardia—Phenylpropanolamine—obesity	6.94e-05	0.00142	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC6A14—obesity	6.78e-05	0.0091	CbGpPWpGaD
Diethylpropion—Urine output increased—Bupropion—obesity	6.65e-05	0.00136	CcSEcCtD
Diethylpropion—Ecchymosis—Bupropion—obesity	6.65e-05	0.00136	CcSEcCtD
Diethylpropion—Tachycardia—Phentermine—obesity	6.64e-05	0.00136	CcSEcCtD
Diethylpropion—Gynaecomastia—Bupropion—obesity	6.58e-05	0.00135	CcSEcCtD
Diethylpropion—Diarrhoea—Methamphetamine—obesity	6.48e-05	0.00133	CcSEcCtD
Diethylpropion—SLC6A3—Parkinsons Disease Pathway—CYCS—obesity	6.44e-05	0.00864	CbGpPWpGaD
Diethylpropion—Insomnia—Phenylpropanolamine—obesity	6.43e-05	0.00132	CcSEcCtD
Diethylpropion—Agitation—Cimetidine—obesity	6.34e-05	0.0013	CcSEcCtD
Diethylpropion—Dyspnoea—Phenylpropanolamine—obesity	6.34e-05	0.0013	CcSEcCtD
Diethylpropion—Somnolence—Phenylpropanolamine—obesity	6.32e-05	0.0013	CcSEcCtD
Diethylpropion—Euphoric mood—Bupropion—obesity	6.32e-05	0.0013	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—FTL—obesity	6.27e-05	0.0084	CbGpPWpGaD
Diethylpropion—Dizziness—Methamphetamine—obesity	6.26e-05	0.00129	CcSEcCtD
Diethylpropion—Diarrhoea—Benzphetamine—obesity	6.25e-05	0.00128	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Sibutramine—obesity	6.25e-05	0.00128	CcSEcCtD
Diethylpropion—Malaise—Cimetidine—obesity	6.22e-05	0.00128	CcSEcCtD
Diethylpropion—Leukopenia—Cimetidine—obesity	6.17e-05	0.00127	CcSEcCtD
Diethylpropion—Insomnia—Phentermine—obesity	6.15e-05	0.00126	CcSEcCtD
Diethylpropion—Constipation—Phenylpropanolamine—obesity	6.08e-05	0.00125	CcSEcCtD
Diethylpropion—Polyuria—Bupropion—obesity	6.08e-05	0.00125	CcSEcCtD
Diethylpropion—Dizziness—Benzphetamine—obesity	6.04e-05	0.00124	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—SLC6A14—obesity	6.01e-05	0.00806	CbGpPWpGaD
Diethylpropion—Dyspepsia—Phentermine—obesity	5.99e-05	0.00123	CcSEcCtD
Diethylpropion—Psychotic disorder—Sibutramine—obesity	5.98e-05	0.00123	CcSEcCtD
Diethylpropion—Headache—Methamphetamine—obesity	5.93e-05	0.00122	CcSEcCtD
Diethylpropion—Myalgia—Cimetidine—obesity	5.87e-05	0.00121	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Phentermine—obesity	5.87e-05	0.00121	CcSEcCtD
Diethylpropion—Mydriasis—Topiramate—obesity	5.87e-05	0.00121	CcSEcCtD
Diethylpropion—Feeling abnormal—Phenylpropanolamine—obesity	5.86e-05	0.0012	CcSEcCtD
Diethylpropion—Anxiety—Cimetidine—obesity	5.85e-05	0.0012	CcSEcCtD
Diethylpropion—Constipation—Phentermine—obesity	5.82e-05	0.00119	CcSEcCtD
Diethylpropion—Headache—Benzphetamine—obesity	5.72e-05	0.00117	CcSEcCtD
Diethylpropion—Diarrhoea—Phendimetrazine—obesity	5.69e-05	0.00117	CcSEcCtD
Diethylpropion—SLC6A2—Monoamine Transport—AGT—obesity	5.68e-05	0.00761	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC16A7—obesity	5.64e-05	0.00756	CbGpPWpGaD
Diethylpropion—SLC6A3—Alpha-synuclein signaling—PRKCD—obesity	5.55e-05	0.00745	CbGpPWpGaD
Diethylpropion—Dizziness—Phendimetrazine—obesity	5.5e-05	0.00113	CcSEcCtD
Diethylpropion—Tachycardia—Cimetidine—obesity	5.49e-05	0.00113	CcSEcCtD
Diethylpropion—Cerebrovascular accident—Bupropion—obesity	5.44e-05	0.00112	CcSEcCtD
Diethylpropion—Nausea—Benzphetamine—obesity	5.42e-05	0.00111	CcSEcCtD
Diethylpropion—Urticaria—Phentermine—obesity	5.4e-05	0.00111	CcSEcCtD
Diethylpropion—Sweating increased—Orlistat—obesity	5.32e-05	0.00109	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—PPARD—obesity	5.25e-05	0.00704	CbGpPWpGaD
Diethylpropion—Abdominal discomfort—Orlistat—obesity	5.24e-05	0.00108	CcSEcCtD
Diethylpropion—Headache—Phendimetrazine—obesity	5.21e-05	0.00107	CcSEcCtD
Diethylpropion—Psychotic disorder—Bupropion—obesity	5.21e-05	0.00107	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—obesity	5.16e-05	0.00691	CbGpPWpGaD
Diethylpropion—Dysmenorrhoea—Topiramate—obesity	5.15e-05	0.00106	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Cimetidine—obesity	5.13e-05	0.00105	CcSEcCtD
Diethylpropion—SLC6A3—Monoamine Transport—AGT—obesity	5.03e-05	0.00674	CbGpPWpGaD
Diethylpropion—Somnolence—Cimetidine—obesity	5.01e-05	0.00103	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC16A7—obesity	5e-05	0.0067	CbGpPWpGaD
Diethylpropion—Dyskinesia—Topiramate—obesity	4.98e-05	0.00102	CcSEcCtD
Diethylpropion—Dysuria—Sibutramine—obesity	4.95e-05	0.00102	CcSEcCtD
Diethylpropion—Nausea—Phendimetrazine—obesity	4.94e-05	0.00101	CcSEcCtD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—GABRA6—obesity	4.87e-05	0.00653	CbGpPWpGaD
Diethylpropion—Erectile dysfunction—Sibutramine—obesity	4.87e-05	0.001	CcSEcCtD
Diethylpropion—Constipation—Cimetidine—obesity	4.81e-05	0.000988	CcSEcCtD
Diethylpropion—SLC6A3—Alpha-synuclein signaling—BAD—obesity	4.71e-05	0.00631	CbGpPWpGaD
Diethylpropion—Ethopropazine—BCHE—obesity	4.7e-05	0.0673	CrCbGaD
Diethylpropion—Dizziness—Phenylpropanolamine—obesity	4.7e-05	0.000965	CcSEcCtD
Diethylpropion—Diarrhoea—Phentermine—obesity	4.65e-05	0.000955	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—PPARD—obesity	4.65e-05	0.00623	CbGpPWpGaD
Diethylpropion—Feeling abnormal—Cimetidine—obesity	4.64e-05	0.000953	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—obesity	4.57e-05	0.00612	CbGpPWpGaD
Diethylpropion—Vomiting—Phenylpropanolamine—obesity	4.52e-05	0.000928	CcSEcCtD
Diethylpropion—Dizziness—Phentermine—obesity	4.5e-05	0.000923	CcSEcCtD
Diethylpropion—Sweating increased—Bupropion—obesity	4.49e-05	0.000922	CcSEcCtD
Diethylpropion—Rash—Phenylpropanolamine—obesity	4.48e-05	0.00092	CcSEcCtD
Diethylpropion—Dermatitis—Phenylpropanolamine—obesity	4.48e-05	0.000919	CcSEcCtD
Diethylpropion—Abdominal discomfort—Bupropion—obesity	4.42e-05	0.000908	CcSEcCtD
Diethylpropion—Pancytopenia—Bupropion—obesity	4.38e-05	0.000899	CcSEcCtD
Diethylpropion—Vomiting—Phentermine—obesity	4.32e-05	0.000888	CcSEcCtD
Diethylpropion—Dysuria—Bupropion—obesity	4.31e-05	0.000885	CcSEcCtD
Diethylpropion—Rash—Phentermine—obesity	4.29e-05	0.00088	CcSEcCtD
Diethylpropion—Dermatitis—Phentermine—obesity	4.28e-05	0.00088	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC6A14—obesity	4.28e-05	0.00573	CbGpPWpGaD
Diethylpropion—Headache—Phentermine—obesity	4.26e-05	0.000875	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—G6PD—obesity	4.26e-05	0.00571	CbGpPWpGaD
Diethylpropion—Erectile dysfunction—Bupropion—obesity	4.25e-05	0.000872	CcSEcCtD
Diethylpropion—Urine output increased—Topiramate—obesity	4.23e-05	0.000869	CcSEcCtD
Diethylpropion—Nausea—Phenylpropanolamine—obesity	4.22e-05	0.000867	CcSEcCtD
Diethylpropion—Nausea—Phentermine—obesity	4.04e-05	0.000829	CcSEcCtD
Diethylpropion—Euphoric mood—Topiramate—obesity	4.02e-05	0.000826	CcSEcCtD
Diethylpropion—Tiaprofenic acid—PTGS2—obesity	3.97e-05	0.0568	CrCbGaD
Diethylpropion—Polyuria—Topiramate—obesity	3.87e-05	0.000795	CcSEcCtD
Diethylpropion—Alopecia—Orlistat—obesity	3.87e-05	0.000794	CcSEcCtD
Diethylpropion—Diarrhoea—Cimetidine—obesity	3.85e-05	0.000791	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC6A14—obesity	3.79e-05	0.00508	CbGpPWpGaD
Diethylpropion—Arrhythmia—Sibutramine—obesity	3.78e-05	0.000777	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—G6PD—obesity	3.77e-05	0.00506	CbGpPWpGaD
Diethylpropion—Alopecia—Sibutramine—obesity	3.74e-05	0.000768	CcSEcCtD
Diethylpropion—SLC6A3—Neuronal System—GABRA6—obesity	3.73e-05	0.00501	CbGpPWpGaD
Diethylpropion—Dizziness—Cimetidine—obesity	3.72e-05	0.000764	CcSEcCtD
Diethylpropion—Tension—Sibutramine—obesity	3.62e-05	0.000743	CcSEcCtD
Diethylpropion—Vision blurred—Orlistat—obesity	3.59e-05	0.000737	CcSEcCtD
Diethylpropion—Nervousness—Sibutramine—obesity	3.58e-05	0.000735	CcSEcCtD
Diethylpropion—Vomiting—Cimetidine—obesity	3.58e-05	0.000735	CcSEcCtD
Diethylpropion—Rash—Cimetidine—obesity	3.55e-05	0.000729	CcSEcCtD
Diethylpropion—Dermatitis—Cimetidine—obesity	3.55e-05	0.000728	CcSEcCtD
Diethylpropion—SLC6A2—Monoamine Transport—IL1B—obesity	3.55e-05	0.00475	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC9A3—obesity	3.54e-05	0.00475	CbGpPWpGaD
Diethylpropion—Ill-defined disorder—Orlistat—obesity	3.53e-05	0.000726	CcSEcCtD
Diethylpropion—Headache—Cimetidine—obesity	3.53e-05	0.000724	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—obesity	3.48e-05	0.00467	CbGpPWpGaD
Diethylpropion—Vision blurred—Sibutramine—obesity	3.47e-05	0.000713	CcSEcCtD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—GLUL—obesity	3.47e-05	0.00466	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—GPX3—obesity	3.46e-05	0.00463	CbGpPWpGaD
Diethylpropion—Tremor—Sibutramine—obesity	3.45e-05	0.000709	CcSEcCtD
Diethylpropion—Malaise—Orlistat—obesity	3.43e-05	0.000705	CcSEcCtD
Diethylpropion—Ill-defined disorder—Sibutramine—obesity	3.42e-05	0.000702	CcSEcCtD
Diethylpropion—Agitation—Sibutramine—obesity	3.39e-05	0.000695	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—HK2—obesity	3.38e-05	0.00453	CbGpPWpGaD
Diethylpropion—Palpitations—Orlistat—obesity	3.37e-05	0.000691	CcSEcCtD
Diethylpropion—Nausea—Cimetidine—obesity	3.34e-05	0.000687	CcSEcCtD
Diethylpropion—Malaise—Sibutramine—obesity	3.32e-05	0.000682	CcSEcCtD
Diethylpropion—Psychotic disorder—Topiramate—obesity	3.32e-05	0.000682	CcSEcCtD
Diethylpropion—Convulsion—Orlistat—obesity	3.3e-05	0.000677	CcSEcCtD
Diethylpropion—Leukopenia—Sibutramine—obesity	3.3e-05	0.000677	CcSEcCtD
Diethylpropion—Arrhythmia—Bupropion—obesity	3.3e-05	0.000677	CcSEcCtD
Diethylpropion—Alopecia—Bupropion—obesity	3.26e-05	0.00067	CcSEcCtD
Diethylpropion—Palpitations—Sibutramine—obesity	3.26e-05	0.000669	CcSEcCtD
Diethylpropion—Chest pain—Orlistat—obesity	3.24e-05	0.000666	CcSEcCtD
Diethylpropion—Myalgia—Orlistat—obesity	3.24e-05	0.000666	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC27A1—obesity	3.24e-05	0.00434	CbGpPWpGaD
Diethylpropion—Anxiety—Orlistat—obesity	3.23e-05	0.000663	CcSEcCtD
Diethylpropion—Discomfort—Orlistat—obesity	3.2e-05	0.000658	CcSEcCtD
Diethylpropion—Convulsion—Sibutramine—obesity	3.19e-05	0.000656	CcSEcCtD
Diethylpropion—Dry mouth—Orlistat—obesity	3.17e-05	0.000651	CcSEcCtD
Diethylpropion—Tension—Bupropion—obesity	3.15e-05	0.000647	CcSEcCtD
Diethylpropion—SLC6A3—Monoamine Transport—IL1B—obesity	3.14e-05	0.00421	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC9A3—obesity	3.14e-05	0.00421	CbGpPWpGaD
Diethylpropion—Myalgia—Sibutramine—obesity	3.14e-05	0.000644	CcSEcCtD
Diethylpropion—Chest pain—Sibutramine—obesity	3.14e-05	0.000644	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—AQP7—obesity	3.13e-05	0.0042	CbGpPWpGaD
Diethylpropion—Anxiety—Sibutramine—obesity	3.13e-05	0.000642	CcSEcCtD
Diethylpropion—Nervousness—Bupropion—obesity	3.12e-05	0.000641	CcSEcCtD
Diethylpropion—Discomfort—Sibutramine—obesity	3.1e-05	0.000637	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—obesity	3.08e-05	0.00414	CbGpPWpGaD
Diethylpropion—Dry mouth—Sibutramine—obesity	3.07e-05	0.00063	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—GPX3—obesity	3.06e-05	0.0041	CbGpPWpGaD
Diethylpropion—Vision blurred—Bupropion—obesity	3.03e-05	0.000622	CcSEcCtD
Diethylpropion—Tremor—Bupropion—obesity	3.01e-05	0.000618	CcSEcCtD
Diethylpropion—Hyperhidrosis—Orlistat—obesity	3e-05	0.000617	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—HK2—obesity	2.99e-05	0.00401	CbGpPWpGaD
Diethylpropion—Selegiline—CYP2E1—obesity	2.99e-05	0.0428	CrCbGaD
Diethylpropion—Ill-defined disorder—Bupropion—obesity	2.98e-05	0.000612	CcSEcCtD
Diethylpropion—Agitation—Bupropion—obesity	2.95e-05	0.000606	CcSEcCtD
Diethylpropion—Tachycardia—Sibutramine—obesity	2.94e-05	0.000603	CcSEcCtD
Diethylpropion—Hyperhidrosis—Sibutramine—obesity	2.91e-05	0.000597	CcSEcCtD
Diethylpropion—Malaise—Bupropion—obesity	2.9e-05	0.000595	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC6A4—obesity	2.9e-05	0.00388	CbGpPWpGaD
Diethylpropion—Leukopenia—Bupropion—obesity	2.88e-05	0.000591	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC27A1—obesity	2.87e-05	0.00385	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC16A7—obesity	2.87e-05	0.00384	CbGpPWpGaD
Diethylpropion—Sweating increased—Topiramate—obesity	2.86e-05	0.000588	CcSEcCtD
Diethylpropion—Palpitations—Bupropion—obesity	2.84e-05	0.000583	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Orlistat—obesity	2.83e-05	0.000581	CcSEcCtD
Diethylpropion—Abdominal discomfort—Topiramate—obesity	2.82e-05	0.000578	CcSEcCtD
Diethylpropion—Insomnia—Orlistat—obesity	2.81e-05	0.000577	CcSEcCtD
Diethylpropion—Pancytopenia—Topiramate—obesity	2.79e-05	0.000573	CcSEcCtD
Diethylpropion—Convulsion—Bupropion—obesity	2.78e-05	0.000572	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—AQP7—obesity	2.78e-05	0.00372	CbGpPWpGaD
Diethylpropion—SLC6A3—Dopaminergic Neurogenesis—STAT3—obesity	2.77e-05	0.00372	CbGpPWpGaD
Diethylpropion—Dysuria—Topiramate—obesity	2.75e-05	0.000564	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Sibutramine—obesity	2.74e-05	0.000563	CcSEcCtD
Diethylpropion—Dyspepsia—Orlistat—obesity	2.74e-05	0.000562	CcSEcCtD
Diethylpropion—Chest pain—Bupropion—obesity	2.74e-05	0.000562	CcSEcCtD
Diethylpropion—Myalgia—Bupropion—obesity	2.74e-05	0.000562	CcSEcCtD
Diethylpropion—Anxiety—Bupropion—obesity	2.73e-05	0.00056	CcSEcCtD
Diethylpropion—Insomnia—Sibutramine—obesity	2.72e-05	0.000559	CcSEcCtD
Diethylpropion—Erectile dysfunction—Topiramate—obesity	2.71e-05	0.000556	CcSEcCtD
Diethylpropion—Discomfort—Bupropion—obesity	2.7e-05	0.000555	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Orlistat—obesity	2.68e-05	0.000551	CcSEcCtD
Diethylpropion—Dyspnoea—Sibutramine—obesity	2.68e-05	0.000551	CcSEcCtD
Diethylpropion—Dry mouth—Bupropion—obesity	2.68e-05	0.000549	CcSEcCtD
Diethylpropion—Somnolence—Sibutramine—obesity	2.67e-05	0.000549	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—LCN2—obesity	2.67e-05	0.00357	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—GLUL—obesity	2.66e-05	0.00357	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—HK1—obesity	2.65e-05	0.00356	CbGpPWpGaD
Diethylpropion—Dyspepsia—Sibutramine—obesity	2.65e-05	0.000544	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—NQO1—obesity	2.62e-05	0.00351	CbGpPWpGaD
Diethylpropion—Gastrointestinal disorder—Sibutramine—obesity	2.6e-05	0.000533	CcSEcCtD
Diethylpropion—Amphetamine—SLC6A4—obesity	2.59e-05	0.0371	CrCbGaD
Diethylpropion—Amphetamine—DRD2—obesity	2.58e-05	0.0369	CrCbGaD
Diethylpropion—SLC6A2—Monoamine Transport—TNF—obesity	2.57e-05	0.00345	CbGpPWpGaD
Diethylpropion—Constipation—Sibutramine—obesity	2.57e-05	0.000528	CcSEcCtD
Diethylpropion—SLC6A3—Dopaminergic Neurogenesis—TGFB1—obesity	2.57e-05	0.00345	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—SLC6A4—obesity	2.57e-05	0.00344	CbGpPWpGaD
Diethylpropion—Feeling abnormal—Orlistat—obesity	2.56e-05	0.000526	CcSEcCtD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—SLC22A1—obesity	2.56e-05	0.00343	CbGpPWpGaD
Diethylpropion—Tachycardia—Bupropion—obesity	2.56e-05	0.000525	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC16A7—obesity	2.54e-05	0.0034	CbGpPWpGaD
Diethylpropion—Hyperhidrosis—Bupropion—obesity	2.54e-05	0.000521	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC2A4—obesity	2.51e-05	0.00337	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—COX7C—obesity	2.51e-05	0.00336	CbGpPWpGaD
Diethylpropion—Feeling abnormal—Sibutramine—obesity	2.48e-05	0.000509	CcSEcCtD
Diethylpropion—Urticaria—Orlistat—obesity	2.47e-05	0.000507	CcSEcCtD
Diethylpropion—Agranulocytosis—Topiramate—obesity	2.44e-05	0.000502	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—GGT1—obesity	2.43e-05	0.00326	CbGpPWpGaD
Diethylpropion—Methamphetamine—SLC6A4—obesity	2.4e-05	0.0344	CrCbGaD
Diethylpropion—Urticaria—Sibutramine—obesity	2.39e-05	0.000491	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Bupropion—obesity	2.39e-05	0.000491	CcSEcCtD
Diethylpropion—Insomnia—Bupropion—obesity	2.37e-05	0.000487	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—LCN2—obesity	2.36e-05	0.00317	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—HK1—obesity	2.35e-05	0.00315	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—obesity	2.34e-05	0.00314	CbGpPWpGaD
Diethylpropion—Dyspnoea—Bupropion—obesity	2.34e-05	0.00048	CcSEcCtD
Diethylpropion—Somnolence—Bupropion—obesity	2.33e-05	0.000479	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—NQO1—obesity	2.32e-05	0.00311	CbGpPWpGaD
Diethylpropion—Dyspepsia—Bupropion—obesity	2.31e-05	0.000474	CcSEcCtD
Diethylpropion—SLC6A3—Monoamine Transport—TNF—obesity	2.28e-05	0.00306	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—FTL—obesity	2.27e-05	0.00304	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GABRA6—obesity	2.27e-05	0.00304	CbGpPWpGaD
Diethylpropion—Gastrointestinal disorder—Bupropion—obesity	2.26e-05	0.000465	CcSEcCtD
Diethylpropion—SLC6A3—Neuronal System—KCNMA1—obesity	2.25e-05	0.00301	CbGpPWpGaD
Diethylpropion—Constipation—Bupropion—obesity	2.24e-05	0.00046	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—SLC2A4—obesity	2.22e-05	0.00298	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—COX7C—obesity	2.22e-05	0.00298	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC6A14—obesity	2.17e-05	0.00291	CbGpPWpGaD
Diethylpropion—Feeling abnormal—Bupropion—obesity	2.16e-05	0.000444	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—HMOX1—obesity	2.15e-05	0.00289	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—GGT1—obesity	2.15e-05	0.00289	CbGpPWpGaD
Diethylpropion—Diarrhoea—Orlistat—obesity	2.13e-05	0.000437	CcSEcCtD
Diethylpropion—Urticaria—Bupropion—obesity	2.08e-05	0.000428	CcSEcCtD
Diethylpropion—Alopecia—Topiramate—obesity	2.08e-05	0.000427	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—obesity	2.08e-05	0.00278	CbGpPWpGaD
Diethylpropion—Diarrhoea—Sibutramine—obesity	2.06e-05	0.000423	CcSEcCtD
Diethylpropion—Dizziness—Orlistat—obesity	2.06e-05	0.000422	CcSEcCtD
Diethylpropion—Erythema—Topiramate—obesity	2.05e-05	0.00042	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—GCK—obesity	2.03e-05	0.00273	CbGpPWpGaD
Diethylpropion—Tension—Topiramate—obesity	2.01e-05	0.000412	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GABRA6—obesity	2.01e-05	0.00269	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—FTL—obesity	2.01e-05	0.00269	CbGpPWpGaD
Diethylpropion—Dizziness—Sibutramine—obesity	1.99e-05	0.000408	CcSEcCtD
Diethylpropion—Nervousness—Topiramate—obesity	1.99e-05	0.000408	CcSEcCtD
Diethylpropion—Vomiting—Orlistat—obesity	1.98e-05	0.000406	CcSEcCtD
Diethylpropion—SLC6A3—Neuronal System—SLC22A1—obesity	1.96e-05	0.00263	CbGpPWpGaD
Diethylpropion—Rash—Orlistat—obesity	1.96e-05	0.000402	CcSEcCtD
Diethylpropion—Dermatitis—Orlistat—obesity	1.96e-05	0.000402	CcSEcCtD
Diethylpropion—Headache—Orlistat—obesity	1.95e-05	0.0004	CcSEcCtD
Diethylpropion—Vision blurred—Topiramate—obesity	1.93e-05	0.000396	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC6A14—obesity	1.92e-05	0.00258	CbGpPWpGaD
Diethylpropion—Tremor—Topiramate—obesity	1.92e-05	0.000394	CcSEcCtD
Diethylpropion—Vomiting—Sibutramine—obesity	1.91e-05	0.000393	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—HMOX1—obesity	1.91e-05	0.00256	CbGpPWpGaD
Diethylpropion—Ill-defined disorder—Topiramate—obesity	1.9e-05	0.00039	CcSEcCtD
Diethylpropion—Rash—Sibutramine—obesity	1.9e-05	0.000389	CcSEcCtD
Diethylpropion—Dermatitis—Sibutramine—obesity	1.89e-05	0.000389	CcSEcCtD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—BCHE—obesity	1.89e-05	0.00253	CbGpPWpGaD
Diethylpropion—Headache—Sibutramine—obesity	1.88e-05	0.000387	CcSEcCtD
Diethylpropion—Agitation—Topiramate—obesity	1.88e-05	0.000386	CcSEcCtD
Diethylpropion—Nausea—Orlistat—obesity	1.85e-05	0.000379	CcSEcCtD
Diethylpropion—Malaise—Topiramate—obesity	1.85e-05	0.000379	CcSEcCtD
Diethylpropion—Leukopenia—Topiramate—obesity	1.83e-05	0.000376	CcSEcCtD
Diethylpropion—Palpitations—Topiramate—obesity	1.81e-05	0.000371	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—GCK—obesity	1.8e-05	0.00242	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC9A3—obesity	1.8e-05	0.00241	CbGpPWpGaD
Diethylpropion—Diarrhoea—Bupropion—obesity	1.79e-05	0.000368	CcSEcCtD
Diethylpropion—Nausea—Sibutramine—obesity	1.79e-05	0.000367	CcSEcCtD
Diethylpropion—Convulsion—Topiramate—obesity	1.77e-05	0.000364	CcSEcCtD
Diethylpropion—Myalgia—Topiramate—obesity	1.74e-05	0.000358	CcSEcCtD
Diethylpropion—Chest pain—Topiramate—obesity	1.74e-05	0.000358	CcSEcCtD
Diethylpropion—Anxiety—Topiramate—obesity	1.74e-05	0.000357	CcSEcCtD
Diethylpropion—Dizziness—Bupropion—obesity	1.73e-05	0.000356	CcSEcCtD
Diethylpropion—Discomfort—Topiramate—obesity	1.72e-05	0.000354	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—HK2—obesity	1.72e-05	0.0023	CbGpPWpGaD
Diethylpropion—Dry mouth—Topiramate—obesity	1.7e-05	0.00035	CcSEcCtD
Diethylpropion—Vomiting—Bupropion—obesity	1.67e-05	0.000342	CcSEcCtD
Diethylpropion—Rash—Bupropion—obesity	1.65e-05	0.000339	CcSEcCtD
Diethylpropion—Dermatitis—Bupropion—obesity	1.65e-05	0.000339	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC27A1—obesity	1.65e-05	0.00221	CbGpPWpGaD
Diethylpropion—Headache—Bupropion—obesity	1.64e-05	0.000337	CcSEcCtD
Diethylpropion—Tachycardia—Topiramate—obesity	1.63e-05	0.000335	CcSEcCtD
Diethylpropion—Hyperhidrosis—Topiramate—obesity	1.62e-05	0.000332	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC9A3—obesity	1.59e-05	0.00214	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—obesity	1.58e-05	0.00212	CbGpPWpGaD
Diethylpropion—Nausea—Bupropion—obesity	1.56e-05	0.00032	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Topiramate—obesity	1.52e-05	0.000313	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—HK2—obesity	1.52e-05	0.00204	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—COMT—obesity	1.51e-05	0.00203	CbGpPWpGaD
Diethylpropion—Insomnia—Topiramate—obesity	1.51e-05	0.00031	CcSEcCtD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—GNB3—obesity	1.49e-05	0.002	CbGpPWpGaD
Diethylpropion—Dyspnoea—Topiramate—obesity	1.49e-05	0.000306	CcSEcCtD
Diethylpropion—Somnolence—Topiramate—obesity	1.49e-05	0.000305	CcSEcCtD
Diethylpropion—Dyspepsia—Topiramate—obesity	1.47e-05	0.000302	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC27A1—obesity	1.46e-05	0.00196	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—BCHE—obesity	1.45e-05	0.00194	CbGpPWpGaD
Diethylpropion—Gastrointestinal disorder—Topiramate—obesity	1.44e-05	0.000296	CcSEcCtD
Diethylpropion—Constipation—Topiramate—obesity	1.43e-05	0.000293	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—obesity	1.4e-05	0.00188	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—TRPV1—obesity	1.4e-05	0.00188	CbGpPWpGaD
Diethylpropion—Feeling abnormal—Topiramate—obesity	1.38e-05	0.000283	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—HK1—obesity	1.35e-05	0.00181	CbGpPWpGaD
Diethylpropion—Urticaria—Topiramate—obesity	1.33e-05	0.000273	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—TRPV1—obesity	1.24e-05	0.00166	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—HK1—obesity	1.19e-05	0.0016	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC22A1—obesity	1.19e-05	0.0016	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—COMT—obesity	1.16e-05	0.00155	CbGpPWpGaD
Diethylpropion—Diarrhoea—Topiramate—obesity	1.14e-05	0.000235	CcSEcCtD
Diethylpropion—SLC6A3—Neuronal System—GNB3—obesity	1.14e-05	0.00153	CbGpPWpGaD
Diethylpropion—Dizziness—Topiramate—obesity	1.1e-05	0.000227	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—PRKAR2B—obesity	1.1e-05	0.00147	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—PRKCB—obesity	1.07e-05	0.00144	CbGpPWpGaD
Diethylpropion—Vomiting—Topiramate—obesity	1.06e-05	0.000218	CcSEcCtD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC22A1—obesity	1.05e-05	0.00141	CbGpPWpGaD
Diethylpropion—Rash—Topiramate—obesity	1.05e-05	0.000216	CcSEcCtD
Diethylpropion—Dermatitis—Topiramate—obesity	1.05e-05	0.000216	CcSEcCtD
Diethylpropion—Headache—Topiramate—obesity	1.05e-05	0.000215	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GCK—obesity	1.03e-05	0.00139	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—CETP—obesity	9.98e-06	0.00134	CbGpPWpGaD
Diethylpropion—Nausea—Topiramate—obesity	9.92e-06	0.000204	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—TF—obesity	9.86e-06	0.00132	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—PRKAR2B—obesity	9.73e-06	0.0013	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—TFRC—obesity	9.46e-06	0.00127	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GCK—obesity	9.16e-06	0.00123	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—CETP—obesity	8.84e-06	0.00118	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—TF—obesity	8.74e-06	0.00117	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—TFRC—obesity	8.38e-06	0.00112	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—PRKCB—obesity	8.22e-06	0.0011	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—TGFB1—obesity	8.18e-06	0.0011	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—ALB—obesity	8.15e-06	0.00109	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC2A4—obesity	8.04e-06	0.00108	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—CYCS—obesity	7.94e-06	0.00106	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—NCOA1—obesity	7.67e-06	0.00103	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—PLG—obesity	7.48e-06	0.001	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—TGFB1—obesity	7.25e-06	0.000972	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—ALB—obesity	7.22e-06	0.000968	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC2A4—obesity	7.12e-06	0.000955	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—CYCS—obesity	7.03e-06	0.000943	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GNB3—obesity	6.93e-06	0.000929	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—HMOX1—obesity	6.9e-06	0.000925	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—NCOA1—obesity	6.8e-06	0.000911	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GNAS—obesity	6.75e-06	0.000905	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—PLG—obesity	6.62e-06	0.000888	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—APOB—obesity	6.61e-06	0.000886	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GNB3—obesity	6.14e-06	0.000823	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—HMOX1—obesity	6.11e-06	0.000819	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GNAS—obesity	5.98e-06	0.000801	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—APOB—obesity	5.85e-06	0.000785	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—PPARA—obesity	5.57e-06	0.000747	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—APOA1—obesity	5.23e-06	0.000701	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—PPARA—obesity	4.94e-06	0.000662	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—APOA1—obesity	4.63e-06	0.000621	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ALB—obesity	4.14e-06	0.000555	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ALB—obesity	3.67e-06	0.000492	CbGpPWpGaD
